Companies sponsors |
Orion Pharma (ganaxolone) |
Others |
Central Manchester Foundation Trust, Willink Unit, Genetic Medicine |
|
Department of Health and Social Care |
|
Manchester centre for genomic medicine |
|
NHS England |
|
Rare Disease Collaborative Network (RDCN) for CDKL5 Bristol Royal Hospital for Children |
|
Welsh Government |
Patient carer groups |
Brain and Spine Foundation |
|
Brain Charity |
|
CDKL5 UK |
|
Epilepsy Action |
|
Epilepsy Society |
|
Findacure |
|
Gene People |
|
Genetic Alliance UK |
|
Neurological Alliance |
|
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
|
Young Epilepsy |
Professional groups |
Association of British Neurologists |
|
Association of Genetic Nurses and Counsellors |
|
British Association of Neurologists |
|
British Geriatrics Society |
|
British Neuropathological Society |
|
British Paediatric Epilepsy Group |
|
British Paediatric Neurology Association |
|
British Society for Cell and Gene Therapy |
|
British Society for Genetic Medicine |
|
British Society for Human Genetics |
|
Epilepsy Nurses Association |
|
Epilepsy Society |
|
Institute of Neurology |
|
International League Against Epilepsy UK |
|
Neonatal and Paediatric Pharmacists Group |
|
Neuromodulation Society of UK and Ireland |
|
Primary Care and Community Neurology Society |
|
Primary Care Neurology Society |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Paediatrics & Child Health |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
UK Clinical Pharmacy Association |
|
UK Genetic Testing Network |
Associated public health groups |
Public Health Wales |
|
UK Health Security Agency |
Evidence review group |
PenTAG Health Technology Assessment |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Cell and Gene Therapy Catapult |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Inherited Metabolic and Lysosomal Disease Service, Cardiff and Vale UHB |
|
Medicines and Healthcare Products Regulatory Agency |
|
National Association of Primary Care |
|
National Pharmacy Association |
|
National Services Division |
|
Neurological Alliance of Scotland |
|
NHS Alliance |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Wales Neurological Alliance |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Brain Research UK |
|
British Neurological Research Trust |
|
Cochrane Cystic Fibrosis & Genetic Disorders Group |
|
Cochrane Epilepsy Group |
|
Cochrane UK |
|
Epilepsy Research UK |
|
Genomics England |
|
MRC Clinical Trials Unit |
|
National Hospital for Neurology and Neurosurgery |
|
National Institute for Health Research |